Dr. Kevin Jae Choi, MD

Dr. Choi practices at Sensa Health in Los Angeles, California.

Dr. Choi's NPI, 1134486681, was assigned on April 20, 2012. Dr. Choi graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2012. Dr. Choi's California license number on file is A156572.

Dr. Choi's primary practice is Sensa Health, at 966 S Western Ave Suite 101 Suite 101, Los Angeles, CA 90006-1014. The practice phone is (213) 267-2256.

Dr. Choi's primary practice is Sensa Health in Los Angeles, California. Dr. Choi is also affiliated with PIH Health Good Samaritan Hospital. The medical group on file is Sensa Health. Dmand AI also links Dr. Choi to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choi practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Choi's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Choi is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Choi's licenses on file in 2 states: California and North Carolina.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Choi treats.

CMS data shows 1,890 Medicare services from Dr. Choi across 13 procedure codes in 2024, for 602 Medicare patients. Medicare paid $138,810 for them. Every service was in an office.

CMS counts 602 Medicare patients who saw Dr. Choi in 2024. The largest group is 75 to 84, with 262 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 84% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Choi's median patient age at 71, with 55% women.

In 2024, Dr. Choi wrote 3,228 Medicare Part D claims for 1,529 patients. 98% of them were for generic drugs. CMS names the drug for 3,118 of them, across 24 drugs with 11 or more claims each, at $61,776 in total drug cost. In 2023, CMS named 3,195 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Choi for performance year 2024, reported individually. Dr. Choi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Choi as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Choi to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Migraine Disorders and Headache Disorders, Primary. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Choi that name 6 trials.

CMS Open Payments shows 96 general payments to Dr. Choi from 22 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 45% of the total. Optinose US, Inc. paid the most, $3,531. It also lists 15 research payments totaling $90,819 from 2022 to 2025, naming 6 clinical trials.

Dmand AI lists 3 awards for Dr. Choi, most recently 1st Place, 21st Annual Research Day in 2009.

Dr. Choi graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2012. Dr. Choi is a member of NHS and American Rhinologic Society.

Dr. Choi is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.